
Joyce O'Shaugnessy, MD, Texas Oncology
Advertisement
Articles by Joyce O'Shaugnessy, MD, Texas Oncology
Advertisement
Latest Updated Articles
Prognostic Tools for Early-Stage HER2+ Breast CancerJanuary 25th 2021
Current Treatment Landscape for HER2+ Breast CancerJanuary 25th 2021
Updated Data for Metastatic HER2+ Breast CancerJanuary 25th 2021
Advertisement
Advertisement
Trending on OncLive
1
FDA CTGTAC Votes in Favor of RP1/Nivolumab Data in Advanced Melanoma
2
FDA Grants Priority Review to Subcutaneous Amivantamab in Head and Neck Cancer
3
Precision Advances Have Transformed Lung Cancer Care, But Key Barriers Persist
4
FDA Awards Orphan Drug Designation to Enzomenib for ALL
5


